Global Clinical Trial Partners taps AG Mednet for endpoint adjudication platform
Global Clinical Trial Partners selected AG Mednet’s cloud-based Judi platform to deliver its single-vendor endpoint adjudication services.
Global Clinical Trial Partners selected AG Mednet’s cloud-based Judi platform to deliver its single-vendor endpoint adjudication services.
PCI Pharma acquired Sherpa Clinical packaging, the company’s third acquisition within the past 12 months in an aim to expand its global presence.
Virtrial’s vision is to replace up to half of the standard clinical trial visits with virtual ones, using a hybrid approach incorporating telemedicine.
The digital health company Antidote Technologies is partnering with PWNHealth, a virtual care company that provides direct-to-patient (DTP) lab services.
DZS Clinical Services has been acquired by the global CRO WDMD in a deal that will expand its service offerings globally with the addition of coverage in Europe and Japan.
The Nuvisan Group is taking on part of Galderma’s R&D capacities site, growing its service lines in bioanalysis, clinical trial supplies, and pharmaceutical analytics
CHDI is extending its collaboration with Evotec through to 2023 to accelerate drug development for Huntington’s disease.
IPT speaks to life sciences lawyer, Jane Summerfield, to interpret the recent guidance from the UK government in the event of a ‘no deal’ Brexit.
In Novartis’ latest restructuring move for 2018, the pharma giant announced plans to sell US generic oral solids and dermatology businesses to Aurobindo Pharma US.